Condensed Consolidated Statements of Operations (USD $)	3 Months Ended		9 Months Ended
	Sep. 30, 2011	Sep. 30, 2010	Sep. 30, 2011	Sep. 30, 2010
Revenue	$ 198,464	$ 368,838	$ 690,817	$ 1,028,268
Operating expenses
Direct costs	(87,399)	(121,841)	(336,714)	(353,740)
Research and development expense	(371,327)	(1,453,987)	(1,131,329)	(4,310,471)
Selling, general and administrative expense	(653,651)	(933,507)	(2,271,369)	(3,214,257)
Total operating expenses	(1,112,377)	(2,509,335)	(3,739,412)	(7,878,468)
Loss from operations	(913,913)	(2,140,497)	(3,048,595)	(6,850,200)
Interest income	595	1,054	2,680	5,270
Other income			53,007
Gain on settlement of obligations			845,000
Loss before taxes	(913,318)	(2,139,443)	(2,147,908)	(6,844,930)
Income tax expense			(14,485)
Net loss	$ (913,318)	$ (2,139,443)	$ (2,162,393)	$ (6,844,930)
Net loss per share, basic (in dollars per share)	$ (0.36)	$ (1.25)	$ (0.86)	$ (3.99)
Net loss per share, diluted (in dollars per share)	$ (0.36)	$ (1.25)	$ (0.86)	$ (3.99)
Weighted average shares outstanding, basic (in shares)	2,562,488	1,715,065	2,524,541	1,715,065
Weighted average shares outstanding, diluted (in shares)	2,562,488	1,715,065	2,524,541	1,715,065